It has been reported that mucosal production of interleukin-6 (IL-6) was due to an adhesion-dependent interaction of bacteria with the mucosa [46], and it has been suggested that CB may reduce UTI symptoms through anti-inflammatory mechanisms [45]. This evidence concerns the gene IL6 and bacterial urinary tract infection.